tradingkey.logo
tradingkey.logo
Search

Cytek Biosciences Inc

CTKB
Add to Watchlist
4.590USD
+0.010+0.22%
Close 07/02, 13:00ETQuotes delayed by 15 min
592.76MMarket Cap
LossP/E TTM

Cytek Biosciences Inc

4.590
+0.010+0.22%
View Detailed Chart
TradingKey 图表
Intraday
1m
30m
1h
D
W
M
D

Today

+0.22%

5 Days

+2.46%

1 Month

+6.00%

6 Months

-6.71%

Year to Date

-9.11%

1 Year

+22.07%

Key Figures
4.580Open
4.680High
889.76KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.69%Turnover Ratio
4.580Prev. Close
4.535Low
2.79MTurnover
LossP/E Static
1.81P/B
0.00%Div Yield TTM
-15.89%ROA
6.18052wk High
0.96Volume Ratio
-6.02MNet Profit
129.14MShares
-0.5786EPS TTM
1.19Beta
-20.93%ROE
2.46052wk Low
3.17%Amplitude
48.16%Gross Margin
592.76MMarket Cap
1.65Reward/Risk
3.50%Risk Rate

Key Insights

Cytek Biosciences Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 70 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 5.69.In the medium term, the stock price is expected to remain stable.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Cytek Biosciences Inc's Score

Industry at a Glance

Industry Ranking
70 / 204
Overall Ranking
171 / 4565
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

Cytek Biosciences Inc Highlights

StrengthsRisks
Cytek Biosciences, Inc. is a cell analysis solutions company. The Company is advancing the cell analysis tools by delivering high-resolution, high-content, and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling (FSP) technology. Its platform includes its core FSP instruments, the Cytek Aurora and Northern Lights systems and the Cytek Aurora CS cell sorter; the Cytek Orion reagent cocktail preparation system; the Enhanced Small Particle (ESP) detection technology; the flow cytometer and imaging products under the Amnis and Guava brands, and reagents, software and service to provide a comprehensive and integrated suite of solutions for its customers. Its Cytek Aurora and Northern Lights systems are used in the study of infectious diseases, immunology, immunotherapy, immuno-oncology, oncology, and drug discovery. The Cytek Orion reagent cocktail preparation system enables researchers to fully automate the preparation of antibody cocktails for flow cytometry.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 201.49M.
Overvalued
The company’s latest PE is -7.93, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 84.13M shares, decreasing 7.74% quarter-over-quarter.
Held by Bill Nygren | OAKMX
Star Investor Bill Nygren | OAKMX holds 1.80M shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 1.40.

Analyst Rating

Based on 4 analysts
Buy
Current Rating
5.688
Target Price
+24.18%
Upside Space

Cytek Biosciences Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Cytek Biosciences Inc Info

Cytek Biosciences, Inc. is a cell analysis solutions company. The Company is advancing the cell analysis tools by delivering high-resolution, high-content, and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling (FSP) technology. Its platform includes its core FSP instruments, the Cytek Aurora and Northern Lights systems and the Cytek Aurora CS cell sorter; the Cytek Orion reagent cocktail preparation system; the Enhanced Small Particle (ESP) detection technology; the flow cytometer and imaging products under the Amnis and Guava brands, and reagents, software and service to provide a comprehensive and integrated suite of solutions for its customers. Its Cytek Aurora and Northern Lights systems are used in the study of infectious diseases, immunology, immunotherapy, immuno-oncology, oncology, and drug discovery. The Cytek Orion reagent cocktail preparation system enables researchers to fully automate the preparation of antibody cocktails for flow cytometry.
Ticker SymbolCTKB
CompanyCytek Biosciences Inc
CEOJiang (Wenbin)
Websitehttps://cytekbio.com

FAQs

What is the current price of Cytek Biosciences Inc (CTKB)?

The current price of Cytek Biosciences Inc (CTKB) is 4.59.

What is the symbol of Cytek Biosciences Inc?

The ticker symbol of Cytek Biosciences Inc is CTKB.

What is the 52-week high of Cytek Biosciences Inc?

The 52-week high of Cytek Biosciences Inc is 6.18.

What is the 52-week low of Cytek Biosciences Inc?

The 52-week low of Cytek Biosciences Inc is 2.46.

What is the market capitalization of Cytek Biosciences Inc?

The market capitalization of Cytek Biosciences Inc is 592.76M.

Is Cytek Biosciences Inc (CTKB) currently rated as Buy, Hold, or Sell?

According to analysts, Cytek Biosciences Inc (CTKB) has an overall rating of Buy, with a price target of 5.69.

What is the Earnings Per Share (EPS TTM) of Cytek Biosciences Inc (CTKB)?

The Earnings Per Share (EPS TTM) of Cytek Biosciences Inc (CTKB) is -0.52.